In ₹ Crore except Per Share Latest Annual	ASIANTNE FY25	BNAGROCHEM FY25	CFEL FY24	CRAVATEX FY22	Peer Average
Valuation — at last close
P/E	93.89×	—	35.06×	◆ 18.93×	27.00× +248%
P/B	◆ 0.31×	—	0.65×	1.97×	1.31× -76%
EV/EBITDA	84.97×	—	◆ -1101.36×	-29.31×	-565.34× +115%
Market Cap	₹16.8 Cr	—	₹89.8 Cr	₹83.1 Cr	₹86.4 Cr -81%
Profitability
EBITDA Margin	◆ 0.69%	-12.51%	-1.69%	-120.33%	-44.84% +102%
Net Income Margin	0.35%	6.60%	50.62%	◆ 179.59%	78.94% -100%
Return on Common Equity	0.36%	10.34%	1.85%	◆ 10.41%	7.53% -95%
Return on Capital Employed	◆ 0.62%	-17.55%	-0.16%	-5.82%	-7.84% +108%
Return on Assets	0.26%	◆ 8.89%	1.77%	8.15%	6.27% -96%
Credit & Quality
Total Debt/Equity	0.24×	0.14×	◆ 0.03×	0.10×	0.09× +167%
Interest Coverage	◆ 0.19×	-4.31×	-3.05×	-4.08×	-3.81× +105%
Scale — latest FY
Revenue / Total Income	₹50.9 Cr	₹299 Cr	₹5.1 Cr	₹2.4 Cr	₹102 Cr -50%
Net Income	₹0.2 Cr	₹19.8 Cr	₹2.6 Cr	₹4.4 Cr	₹8.9 Cr -98%
Total Assets	₹71.7 Cr	₹372 Cr	₹144 Cr	₹53.9 Cr	₹190 Cr -62%
EPS	₹0.09	—	₹1.02	₹16.98	₹9 -99%
Book Value per Share	₹27.18	—	₹55.22	₹163.17	₹109.2 -75%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY25 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.